Casandra
Casandra Test Code QD98292Version 1 (DRAFT)
Performing Lab
SARS‑CoV‑2 RNA (COVID‑19) and Respiratory Viral Panel, Qualitative NAAT
Also known as: Parainfluenza, Novel Coronavirus, Adenovirus, Wuhan, COVID19
Clinical Use
Order TestUse
This qualitative nucleic acid amplification test (NAAT) detects SARS‑CoV‑2 RNA along with multiple other respiratory viral pathogens in a single specimen, facilitating differential diagnosis of COVID‑19 versus other viral infections; aids timely clinical decision‑making in patients presenting with acute respiratory symptoms.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
PCR-based (PCR)
Biomarkers
13 targets
AdenovirusHuman MetapneumovirusHuman Parainfluenza Virus 1Human Parainfluenza Virus 2Human Parainfluenza Virus 3Human RSV AHuman RSV BInfluenza A+5 more
Result Turnaround Time
2-3 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Nasal Swab
Volume
Not provided
Minimum Volume
Not provided
Related Tests
Other tests from different labs that may be relevant
